Ester Piek
Impact in
- Molecular Biology top 2%
- TGF-β signaling in diseases
- Angiogenesis and VEGF in Cancer
- Developmental Biology and Gene Regulation
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- TGF-β signaling in diseases 22
- Gene expression and cancer classification 3
- Epigenetics and DNA Methylation 2
- Bone Metabolism and Diseases 2
- Bioinformatics and Genomic Networks 2
- Genetics 2
- Mesenchymal stem cell research 2
- Co-authors
- Peter ten Dijke (12 shared papers)Carl‐Henrik Heldin (6 shared papers)Erwin P. Böttinger (8 shared papers)Anita B. Roberts (9 shared papers)Jiří Zavadil (2 shared papers)Yaw-Ching Yang (2 shared papers)Aristidis Moustakas (1 shared paper)Akira Kurisaki (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Journal of Cellular Physiology (2 papers)International Journal of Cancer (2 papers)The FASEB Journal (2 papers)Endocrinology (2 papers)
- Partner nations
- NetherlandsUnited StatesSweden
In The Last Decade
Ester Piek
38 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 2.8k
- Nephrology 214
- Hepatology 164
- Genetics 154
- Rheumatology 222
Countries citing papers authored by Ester Piek
This map shows the geographic impact of Ester Piek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Piek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Piek more than expected).
Fields of papers citing papers by Ester Piek
This network shows the impact of papers produced by Ester Piek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Piek. The network helps show where Ester Piek may publish in the future.
Co-authors
The 25 scholars most cited alongside Ester Piek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specificity, diversity, and regulation in TGF-beta superfamily signaling. | 1999 | 696 |
| 2 | 1999 | 607 | |
| 3 | 2001 | 468 | |
| 4 | 1999 | 382 | |
| 5 | 2001 | 365 | |
| 6 | 2003 | 334 | |
| 7 | 2003 | 184 | |
| 8 | 2004 | 175 | |
| 9 | Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. | 2003 | 159 |
| 10 | 1998 | 141 | |
| 11 | 2004 | 141 | |
| 12 | 2000 | 109 | |
| 13 | 2001 | 95 | |
| 14 | 2009 | 91 | |
| 15 | 2001 | 87 | |
| 16 | 2001 | 84 | |
| 17 | 2011 | 82 | |
| 18 | 1999 | 72 | |
| 19 | 2006 | 60 | |
| 20 | 2011 | 60 |
About Ester Piek
Ester Piek is a scholar working on Molecular Biology, Genetics, Rheumatology, Endocrinology, Diabetes and Metabolism and General Health Professions, having authored 39 papers that have together received 4.8k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (22 papers), Gene expression and cancer classification (3 papers), Epigenetics and DNA Methylation (2 papers), Bone Metabolism and Diseases (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Mesenchymal stem cell research (2 papers), Bioinformatics and Genomic Networks (2 papers) and Healthcare cost, quality, practices (2 papers). The work is most often cited by research in Molecular Biology (2.8k citations), Nephrology (214 citations), Hepatology (164 citations), Genetics (154 citations) and Rheumatology (222 citations). Ester Piek has collaborated with scholars based in Netherlands, United States and Sweden. Frequent co-authors include Peter ten Dijke, Carl‐Henrik Heldin, Erwin P. Böttinger, Anita B. Roberts, Jiří Zavadil, Yaw-Ching Yang, Aristidis Moustakas, Akira Kurisaki, Susanne Kneitz and Aldo B. Massimi. Their work appears in journals such as Journal of Biological Chemistry, Journal of Cellular Physiology, International Journal of Cancer, The FASEB Journal and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.